Questex, an events company that also partners with HSMAI, announced it has acquired ExL Events Inc., expanding its presence in the global pharmaceutical, life-science and healthcare markets.
ExL Events, founded in 2004 as ExL Pharma, aims to develop innovative, educational conferences that serve the pharmaceutical, life-science and healthcare communities. Kerry Gumas, Questex president and chief executive officer, said ExL will complement the services currently provided to those markets by Questex's Fierce Life Science & Healthcare group of digital media titles and events.
The founders of ExL Events, Bryon Main, president & chief executive officer, and Ethan Denkensohn, chief financial & operating officer, will continue to lead the organization and retain their existing staff.
"For the last 12 years, ExL Events has served the informational and networking needs of the dynamic and rapidly evolving global healthcare and pharmaceutical sectors through high-quality conferences that deliver important topical information and interactive networking opportunities," Main said. "Having Questex's many resources at our fingertips will fuel investment and global expansion opportunities for ExL Events. We look forward to working together to drive growth and innovation for the business.”
ExL Events, which will continue to operate from its New York headquarters, produces more than 70 annual events in the United States, Europe and Asia for pharmaceutical, biotechnology, medical device, diagnostics and contract-research organizations, hospitals and physicians, among others.
Financial terms of the agreement between Questex and ExL were not released.
